Invisio currently has a number of product opportunities available for partnering.
Currently Invisio Pharma is generating a portfolio of products at a variety of stages of development. We focus on New Therapeutic Entities – products that have already been approved but can be re-profiled – improved products to fulfil a strong patient need. This allows us to focus on dynamic and fast development timelines, requiring small investments of time and funding to reach commercialisation. At present we are focussing on:
All these products are available for partial or full funding, joint venture activity or out-licensing.